nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCB1—colon cancer	0.271	1	CbGaD
Indinavir—ABCC1—Irinotecan—colon cancer	0.06	0.1	CbGbCtD
Indinavir—ABCC1—Vincristine—colon cancer	0.0525	0.0875	CbGbCtD
Indinavir—SLCO1B1—Irinotecan—colon cancer	0.0506	0.0844	CbGbCtD
Indinavir—ABCC2—Irinotecan—colon cancer	0.0444	0.0741	CbGbCtD
Indinavir—ABCC2—Vincristine—colon cancer	0.0388	0.0648	CbGbCtD
Indinavir—ABCC1—Methotrexate—colon cancer	0.0318	0.053	CbGbCtD
Indinavir—CYP3A7—Irinotecan—colon cancer	0.0297	0.0495	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0297	0.0495	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—colon cancer	0.0284	0.0473	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—colon cancer	0.0268	0.0446	CbGbCtD
Indinavir—CYP3A7—Vincristine—colon cancer	0.0259	0.0433	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0259	0.0433	CbGbCtD
Indinavir—CYP2C9—Capecitabine—colon cancer	0.0242	0.0403	CbGbCtD
Indinavir—ABCC2—Methotrexate—colon cancer	0.0235	0.0392	CbGbCtD
Indinavir—CYP3A5—Irinotecan—colon cancer	0.0223	0.0371	CbGbCtD
Indinavir—CYP3A5—Vincristine—colon cancer	0.0195	0.0325	CbGbCtD
Indinavir—ABCB1—Irinotecan—colon cancer	0.0145	0.0242	CbGbCtD
Indinavir—CYP2C9—Fluorouracil—colon cancer	0.0143	0.0239	CbGbCtD
Indinavir—ABCB1—Vincristine—colon cancer	0.0127	0.0211	CbGbCtD
Indinavir—CYP3A4—Irinotecan—colon cancer	0.00868	0.0145	CbGbCtD
Indinavir—ABCB1—Methotrexate—colon cancer	0.00767	0.0128	CbGbCtD
Indinavir—CYP3A4—Vincristine—colon cancer	0.00759	0.0127	CbGbCtD
Indinavir—ABCC2—bile—colon cancer	0.00363	0.224	CbGeAlD
Indinavir—Lopinavir—ABCB1—colon cancer	0.000777	0.39	CrCbGaD
Indinavir—Nelfinavir—ABCB1—colon cancer	0.000723	0.362	CrCbGaD
Indinavir—SLCO1B1—renal system—colon cancer	0.000637	0.0394	CbGeAlD
Indinavir—CYP3A7—liver—colon cancer	0.000568	0.0351	CbGeAlD
Indinavir—SLC22A1—renal system—colon cancer	0.000539	0.0333	CbGeAlD
Indinavir—SLCO1B1—digestive system—colon cancer	0.000523	0.0323	CbGeAlD
Indinavir—SLCO1A2—renal system—colon cancer	0.000519	0.032	CbGeAlD
Indinavir—Saquinavir—ABCB1—colon cancer	0.000495	0.248	CrCbGaD
Indinavir—ABCC2—renal system—colon cancer	0.000483	0.0298	CbGeAlD
Indinavir—CYP3A7-CYP3A51P—liver—colon cancer	0.000483	0.0298	CbGeAlD
Indinavir—SLCO1A2—digestive system—colon cancer	0.000425	0.0263	CbGeAlD
Indinavir—ABCC2—digestive system—colon cancer	0.000396	0.0245	CbGeAlD
Indinavir—SLC22A1—vagina—colon cancer	0.00039	0.0241	CbGeAlD
Indinavir—SLCO1B1—liver—colon cancer	0.00039	0.0241	CbGeAlD
Indinavir—ABCB1—blood vessel—colon cancer	0.000385	0.0238	CbGeAlD
Indinavir—CYP2C19—digestive system—colon cancer	0.000341	0.021	CbGeAlD
Indinavir—SLC22A1—liver—colon cancer	0.000329	0.0203	CbGeAlD
Indinavir—CYP3A5—renal system—colon cancer	0.000327	0.0202	CbGeAlD
Indinavir—SLCO1A2—liver—colon cancer	0.000317	0.0196	CbGeAlD
Indinavir—ABCC1—vagina—colon cancer	0.000308	0.019	CbGeAlD
Indinavir—CYP2C19—vagina—colon cancer	0.000301	0.0186	CbGeAlD
Indinavir—ABCC2—liver—colon cancer	0.000295	0.0182	CbGeAlD
Indinavir—CYP3A5—digestive system—colon cancer	0.000268	0.0166	CbGeAlD
Indinavir—Muscle spasms—Irinotecan—colon cancer	0.000265	0.00238	CcSEcCtD
Indinavir—CYP2C9—digestive system—colon cancer	0.000264	0.0163	CbGeAlD
Indinavir—Diabetes mellitus—Methotrexate—colon cancer	0.000262	0.00236	CcSEcCtD
Indinavir—Anaemia—Vincristine—colon cancer	0.000261	0.00235	CcSEcCtD
Indinavir—ABCC1—liver—colon cancer	0.00026	0.0161	CbGeAlD
Indinavir—Agitation—Vincristine—colon cancer	0.00026	0.00234	CcSEcCtD
Indinavir—Angina pectoris—Capecitabine—colon cancer	0.000258	0.00232	CcSEcCtD
Indinavir—Ill-defined disorder—Irinotecan—colon cancer	0.000255	0.0023	CcSEcCtD
Indinavir—Anaemia—Irinotecan—colon cancer	0.000254	0.00229	CcSEcCtD
Indinavir—Vertigo—Vincristine—colon cancer	0.000254	0.00229	CcSEcCtD
Indinavir—CYP2C19—liver—colon cancer	0.000254	0.0157	CbGeAlD
Indinavir—Hepatic failure—Methotrexate—colon cancer	0.000253	0.00228	CcSEcCtD
Indinavir—Vision blurred—Fluorouracil—colon cancer	0.000248	0.00224	CcSEcCtD
Indinavir—Malaise—Irinotecan—colon cancer	0.000248	0.00223	CcSEcCtD
Indinavir—Vertigo—Irinotecan—colon cancer	0.000247	0.00223	CcSEcCtD
Indinavir—Dysuria—Capecitabine—colon cancer	0.000247	0.00222	CcSEcCtD
Indinavir—Syncope—Irinotecan—colon cancer	0.000247	0.00222	CcSEcCtD
Indinavir—Renal failure acute—Methotrexate—colon cancer	0.000247	0.00222	CcSEcCtD
Indinavir—Upper respiratory tract infection—Capecitabine—colon cancer	0.000246	0.00221	CcSEcCtD
Indinavir—CYP3A4—renal system—colon cancer	0.000246	0.0152	CbGeAlD
Indinavir—Anaemia—Fluorouracil—colon cancer	0.000244	0.00219	CcSEcCtD
Indinavir—Loss of consciousness—Irinotecan—colon cancer	0.000242	0.00218	CcSEcCtD
Indinavir—CYP2D6—renal system—colon cancer	0.000242	0.0149	CbGeAlD
Indinavir—Myalgia—Vincristine—colon cancer	0.000241	0.00217	CcSEcCtD
Indinavir—Weight increased—Capecitabine—colon cancer	0.000241	0.00217	CcSEcCtD
Indinavir—Cough—Irinotecan—colon cancer	0.00024	0.00216	CcSEcCtD
Indinavir—Hyperglycaemia—Capecitabine—colon cancer	0.000238	0.00215	CcSEcCtD
Indinavir—Pneumonia—Capecitabine—colon cancer	0.000237	0.00213	CcSEcCtD
Indinavir—CYP3A5—vagina—colon cancer	0.000237	0.0146	CbGeAlD
Indinavir—Anaphylactoid reaction—Methotrexate—colon cancer	0.000235	0.00212	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000234	0.0021	CcSEcCtD
Indinavir—Acute coronary syndrome—Capecitabine—colon cancer	0.000232	0.00209	CcSEcCtD
Indinavir—Renal failure—Capecitabine—colon cancer	0.000232	0.00209	CcSEcCtD
Indinavir—Discomfort—Irinotecan—colon cancer	0.000232	0.00208	CcSEcCtD
Indinavir—Neuropathy peripheral—Capecitabine—colon cancer	0.000231	0.00208	CcSEcCtD
Indinavir—Myocardial infarction—Capecitabine—colon cancer	0.000231	0.00208	CcSEcCtD
Indinavir—Anaphylactic shock—Vincristine—colon cancer	0.000231	0.00208	CcSEcCtD
Indinavir—Oedema—Vincristine—colon cancer	0.000231	0.00208	CcSEcCtD
Indinavir—Jaundice—Capecitabine—colon cancer	0.00023	0.00207	CcSEcCtD
Indinavir—ABCB1—embryo—colon cancer	0.00023	0.0142	CbGeAlD
Indinavir—Urinary tract infection—Capecitabine—colon cancer	0.000229	0.00206	CcSEcCtD
Indinavir—ABCC2—lymph node—colon cancer	0.000226	0.014	CbGeAlD
Indinavir—Nervous system disorder—Vincristine—colon cancer	0.000226	0.00204	CcSEcCtD
Indinavir—Thrombocytopenia—Vincristine—colon cancer	0.000226	0.00203	CcSEcCtD
Indinavir—Haematuria—Capecitabine—colon cancer	0.000225	0.00202	CcSEcCtD
Indinavir—Anaphylactic shock—Irinotecan—colon cancer	0.000225	0.00202	CcSEcCtD
Indinavir—Oedema—Irinotecan—colon cancer	0.000225	0.00202	CcSEcCtD
Indinavir—Chest pain—Fluorouracil—colon cancer	0.000224	0.00202	CcSEcCtD
Indinavir—Myalgia—Fluorouracil—colon cancer	0.000224	0.00202	CcSEcCtD
Indinavir—Hyperhidrosis—Vincristine—colon cancer	0.000223	0.00201	CcSEcCtD
Indinavir—Hepatobiliary disease—Capecitabine—colon cancer	0.000223	0.00201	CcSEcCtD
Indinavir—Discomfort—Fluorouracil—colon cancer	0.000222	0.002	CcSEcCtD
Indinavir—Shock—Irinotecan—colon cancer	0.000221	0.00199	CcSEcCtD
Indinavir—Nervous system disorder—Irinotecan—colon cancer	0.00022	0.00198	CcSEcCtD
Indinavir—Thrombocytopenia—Irinotecan—colon cancer	0.00022	0.00198	CcSEcCtD
Indinavir—Anorexia—Vincristine—colon cancer	0.00022	0.00198	CcSEcCtD
Indinavir—Hyperhidrosis—Irinotecan—colon cancer	0.000217	0.00195	CcSEcCtD
Indinavir—Oedema—Fluorouracil—colon cancer	0.000215	0.00194	CcSEcCtD
Indinavir—Anaphylactic shock—Fluorouracil—colon cancer	0.000215	0.00194	CcSEcCtD
Indinavir—Anorexia—Irinotecan—colon cancer	0.000214	0.00193	CcSEcCtD
Indinavir—Haemoglobin—Capecitabine—colon cancer	0.000213	0.00191	CcSEcCtD
Indinavir—Hepatitis—Capecitabine—colon cancer	0.000212	0.0019	CcSEcCtD
Indinavir—Haemorrhage—Capecitabine—colon cancer	0.000212	0.0019	CcSEcCtD
Indinavir—Nervous system disorder—Fluorouracil—colon cancer	0.000211	0.0019	CcSEcCtD
Indinavir—Thrombocytopenia—Fluorouracil—colon cancer	0.000211	0.0019	CcSEcCtD
Indinavir—Hypoaesthesia—Capecitabine—colon cancer	0.000211	0.00189	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Vincristine—colon cancer	0.00021	0.00189	CcSEcCtD
Indinavir—Pharyngitis—Capecitabine—colon cancer	0.00021	0.00189	CcSEcCtD
Indinavir—Urinary tract disorder—Capecitabine—colon cancer	0.000209	0.00188	CcSEcCtD
Indinavir—Insomnia—Vincristine—colon cancer	0.000209	0.00188	CcSEcCtD
Indinavir—Connective tissue disorder—Capecitabine—colon cancer	0.000208	0.00187	CcSEcCtD
Indinavir—Urethral disorder—Capecitabine—colon cancer	0.000207	0.00187	CcSEcCtD
Indinavir—Paraesthesia—Vincristine—colon cancer	0.000207	0.00186	CcSEcCtD
Indinavir—Anorexia—Fluorouracil—colon cancer	0.000205	0.00185	CcSEcCtD
Indinavir—Insomnia—Irinotecan—colon cancer	0.000203	0.00183	CcSEcCtD
Indinavir—Paraesthesia—Irinotecan—colon cancer	0.000202	0.00182	CcSEcCtD
Indinavir—CYP3A4—digestive system—colon cancer	0.000201	0.0124	CbGeAlD
Indinavir—Decreased appetite—Vincristine—colon cancer	0.000201	0.0018	CcSEcCtD
Indinavir—Dyspnoea—Irinotecan—colon cancer	0.0002	0.0018	CcSEcCtD
Indinavir—Erythema multiforme—Capecitabine—colon cancer	0.0002	0.0018	CcSEcCtD
Indinavir—CYP3A5—liver—colon cancer	0.0002	0.0123	CbGeAlD
Indinavir—Somnolence—Irinotecan—colon cancer	0.0002	0.0018	CcSEcCtD
Indinavir—ABCC1—lymph node—colon cancer	0.000199	0.0123	CbGeAlD
Indinavir—Gastrointestinal disorder—Vincristine—colon cancer	0.000199	0.00179	CcSEcCtD
Indinavir—Fatigue—Vincristine—colon cancer	0.000199	0.00179	CcSEcCtD
Indinavir—CYP2D6—digestive system—colon cancer	0.000198	0.0122	CbGeAlD
Indinavir—Dyspepsia—Irinotecan—colon cancer	0.000198	0.00178	CcSEcCtD
Indinavir—Pain—Vincristine—colon cancer	0.000197	0.00178	CcSEcCtD
Indinavir—Constipation—Vincristine—colon cancer	0.000197	0.00178	CcSEcCtD
Indinavir—CYP2C9—liver—colon cancer	0.000197	0.0121	CbGeAlD
Indinavir—Flushing—Capecitabine—colon cancer	0.000196	0.00177	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000196	0.00176	CcSEcCtD
Indinavir—Decreased appetite—Irinotecan—colon cancer	0.000195	0.00176	CcSEcCtD
Indinavir—Insomnia—Fluorouracil—colon cancer	0.000195	0.00175	CcSEcCtD
Indinavir—Gastrointestinal disorder—Irinotecan—colon cancer	0.000194	0.00175	CcSEcCtD
Indinavir—Fatigue—Irinotecan—colon cancer	0.000194	0.00174	CcSEcCtD
Indinavir—Paraesthesia—Fluorouracil—colon cancer	0.000193	0.00174	CcSEcCtD
Indinavir—Pancreatitis—Methotrexate—colon cancer	0.000193	0.00174	CcSEcCtD
Indinavir—Pain—Irinotecan—colon cancer	0.000192	0.00173	CcSEcCtD
Indinavir—Constipation—Irinotecan—colon cancer	0.000192	0.00173	CcSEcCtD
Indinavir—Dyspnoea—Fluorouracil—colon cancer	0.000192	0.00173	CcSEcCtD
Indinavir—Somnolence—Fluorouracil—colon cancer	0.000191	0.00172	CcSEcCtD
Indinavir—Immune system disorder—Capecitabine—colon cancer	0.000191	0.00172	CcSEcCtD
Indinavir—Chills—Capecitabine—colon cancer	0.00019	0.00171	CcSEcCtD
Indinavir—Dyspepsia—Fluorouracil—colon cancer	0.000189	0.0017	CcSEcCtD
Indinavir—Gastrointestinal pain—Vincristine—colon cancer	0.000189	0.0017	CcSEcCtD
Indinavir—ABCB1—epithelium—colon cancer	0.000187	0.0116	CbGeAlD
Indinavir—Decreased appetite—Fluorouracil—colon cancer	0.000187	0.00168	CcSEcCtD
Indinavir—Alopecia—Capecitabine—colon cancer	0.000187	0.00168	CcSEcCtD
Indinavir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000186	0.00167	CcSEcCtD
Indinavir—Feeling abnormal—Irinotecan—colon cancer	0.000185	0.00167	CcSEcCtD
Indinavir—Malnutrition—Capecitabine—colon cancer	0.000184	0.00166	CcSEcCtD
Indinavir—Dysuria—Methotrexate—colon cancer	0.000184	0.00166	CcSEcCtD
Indinavir—Pain—Fluorouracil—colon cancer	0.000184	0.00166	CcSEcCtD
Indinavir—Gastrointestinal pain—Irinotecan—colon cancer	0.000184	0.00165	CcSEcCtD
Indinavir—Upper respiratory tract infection—Methotrexate—colon cancer	0.000183	0.00165	CcSEcCtD
Indinavir—Abdominal pain—Vincristine—colon cancer	0.000182	0.00164	CcSEcCtD
Indinavir—Body temperature increased—Vincristine—colon cancer	0.000182	0.00164	CcSEcCtD
Indinavir—Flatulence—Capecitabine—colon cancer	0.000182	0.00163	CcSEcCtD
Indinavir—Dysgeusia—Capecitabine—colon cancer	0.00018	0.00162	CcSEcCtD
Indinavir—Back pain—Capecitabine—colon cancer	0.000178	0.0016	CcSEcCtD
Indinavir—Body temperature increased—Irinotecan—colon cancer	0.000178	0.0016	CcSEcCtD
Indinavir—Abdominal pain—Irinotecan—colon cancer	0.000178	0.0016	CcSEcCtD
Indinavir—Feeling abnormal—Fluorouracil—colon cancer	0.000177	0.0016	CcSEcCtD
Indinavir—Muscle spasms—Capecitabine—colon cancer	0.000177	0.00159	CcSEcCtD
Indinavir—Pneumonia—Methotrexate—colon cancer	0.000177	0.00159	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000174	0.00157	CcSEcCtD
Indinavir—ABCB1—renal system—colon cancer	0.000174	0.0107	CbGeAlD
Indinavir—Vision blurred—Capecitabine—colon cancer	0.000174	0.00156	CcSEcCtD
Indinavir—Tremor—Capecitabine—colon cancer	0.000173	0.00155	CcSEcCtD
Indinavir—Renal failure—Methotrexate—colon cancer	0.000173	0.00155	CcSEcCtD
Indinavir—Ill-defined disorder—Capecitabine—colon cancer	0.000171	0.00154	CcSEcCtD
Indinavir—Urticaria—Fluorouracil—colon cancer	0.000171	0.00154	CcSEcCtD
Indinavir—Anaemia—Capecitabine—colon cancer	0.00017	0.00153	CcSEcCtD
Indinavir—Body temperature increased—Fluorouracil—colon cancer	0.00017	0.00153	CcSEcCtD
Indinavir—Hypersensitivity—Vincristine—colon cancer	0.00017	0.00153	CcSEcCtD
Indinavir—Sweating—Methotrexate—colon cancer	0.000168	0.00151	CcSEcCtD
Indinavir—Haematuria—Methotrexate—colon cancer	0.000167	0.00151	CcSEcCtD
Indinavir—Malaise—Capecitabine—colon cancer	0.000166	0.0015	CcSEcCtD
Indinavir—Hepatobiliary disease—Methotrexate—colon cancer	0.000166	0.00149	CcSEcCtD
Indinavir—Vertigo—Capecitabine—colon cancer	0.000166	0.00149	CcSEcCtD
Indinavir—Hypersensitivity—Irinotecan—colon cancer	0.000166	0.00149	CcSEcCtD
Indinavir—Asthenia—Vincristine—colon cancer	0.000165	0.00149	CcSEcCtD
Indinavir—Syncope—Capecitabine—colon cancer	0.000165	0.00149	CcSEcCtD
Indinavir—Palpitations—Capecitabine—colon cancer	0.000163	0.00147	CcSEcCtD
Indinavir—Loss of consciousness—Capecitabine—colon cancer	0.000162	0.00146	CcSEcCtD
Indinavir—Asthenia—Irinotecan—colon cancer	0.000161	0.00145	CcSEcCtD
Indinavir—Cough—Capecitabine—colon cancer	0.000161	0.00145	CcSEcCtD
Indinavir—Hypersensitivity—Fluorouracil—colon cancer	0.000159	0.00143	CcSEcCtD
Indinavir—Haemoglobin—Methotrexate—colon cancer	0.000158	0.00142	CcSEcCtD
Indinavir—Diarrhoea—Vincristine—colon cancer	0.000158	0.00142	CcSEcCtD
Indinavir—Haemorrhage—Methotrexate—colon cancer	0.000158	0.00142	CcSEcCtD
Indinavir—Hepatitis—Methotrexate—colon cancer	0.000158	0.00142	CcSEcCtD
Indinavir—Arthralgia—Capecitabine—colon cancer	0.000157	0.00141	CcSEcCtD
Indinavir—Chest pain—Capecitabine—colon cancer	0.000157	0.00141	CcSEcCtD
Indinavir—Myalgia—Capecitabine—colon cancer	0.000157	0.00141	CcSEcCtD
Indinavir—Pharyngitis—Methotrexate—colon cancer	0.000156	0.00141	CcSEcCtD
Indinavir—Anxiety—Capecitabine—colon cancer	0.000156	0.00141	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000156	0.0014	CcSEcCtD
Indinavir—Urinary tract disorder—Methotrexate—colon cancer	0.000156	0.0014	CcSEcCtD
Indinavir—Discomfort—Capecitabine—colon cancer	0.000155	0.00139	CcSEcCtD
Indinavir—Urethral disorder—Methotrexate—colon cancer	0.000154	0.00139	CcSEcCtD
Indinavir—Diarrhoea—Irinotecan—colon cancer	0.000154	0.00138	CcSEcCtD
Indinavir—Dry mouth—Capecitabine—colon cancer	0.000153	0.00138	CcSEcCtD
Indinavir—Dizziness—Vincristine—colon cancer	0.000153	0.00137	CcSEcCtD
Indinavir—Pruritus—Fluorouracil—colon cancer	0.000152	0.00137	CcSEcCtD
Indinavir—Oedema—Capecitabine—colon cancer	0.00015	0.00135	CcSEcCtD
Indinavir—CYP3A4—liver—colon cancer	0.00015	0.00926	CbGeAlD
Indinavir—Erythema multiforme—Methotrexate—colon cancer	0.000149	0.00134	CcSEcCtD
Indinavir—Dizziness—Irinotecan—colon cancer	0.000149	0.00134	CcSEcCtD
Indinavir—Shock—Capecitabine—colon cancer	0.000148	0.00133	CcSEcCtD
Indinavir—CYP2D6—liver—colon cancer	0.000148	0.00912	CbGeAlD
Indinavir—Nervous system disorder—Capecitabine—colon cancer	0.000147	0.00133	CcSEcCtD
Indinavir—Diarrhoea—Fluorouracil—colon cancer	0.000147	0.00132	CcSEcCtD
Indinavir—Thrombocytopenia—Capecitabine—colon cancer	0.000147	0.00132	CcSEcCtD
Indinavir—Vomiting—Vincristine—colon cancer	0.000147	0.00132	CcSEcCtD
Indinavir—Skin disorder—Capecitabine—colon cancer	0.000146	0.00131	CcSEcCtD
Indinavir—Rash—Vincristine—colon cancer	0.000145	0.00131	CcSEcCtD
Indinavir—Hyperhidrosis—Capecitabine—colon cancer	0.000145	0.00131	CcSEcCtD
Indinavir—Dermatitis—Vincristine—colon cancer	0.000145	0.00131	CcSEcCtD
Indinavir—Headache—Vincristine—colon cancer	0.000145	0.0013	CcSEcCtD
Indinavir—ABCB1—lymphoid tissue—colon cancer	0.000144	0.00891	CbGeAlD
Indinavir—Anorexia—Capecitabine—colon cancer	0.000143	0.00129	CcSEcCtD
Indinavir—Vomiting—Irinotecan—colon cancer	0.000143	0.00129	CcSEcCtD
Indinavir—ABCB1—digestive system—colon cancer	0.000143	0.0088	CbGeAlD
Indinavir—Immune system disorder—Methotrexate—colon cancer	0.000142	0.00128	CcSEcCtD
Indinavir—Dizziness—Fluorouracil—colon cancer	0.000142	0.00128	CcSEcCtD
Indinavir—Rash—Irinotecan—colon cancer	0.000142	0.00127	CcSEcCtD
Indinavir—Dermatitis—Irinotecan—colon cancer	0.000142	0.00127	CcSEcCtD
Indinavir—Chills—Methotrexate—colon cancer	0.000141	0.00127	CcSEcCtD
Indinavir—Headache—Irinotecan—colon cancer	0.000141	0.00127	CcSEcCtD
Indinavir—Alopecia—Methotrexate—colon cancer	0.000139	0.00125	CcSEcCtD
Indinavir—Malnutrition—Methotrexate—colon cancer	0.000137	0.00123	CcSEcCtD
Indinavir—Nausea—Vincristine—colon cancer	0.000137	0.00123	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000137	0.00123	CcSEcCtD
Indinavir—Vomiting—Fluorouracil—colon cancer	0.000137	0.00123	CcSEcCtD
Indinavir—Insomnia—Capecitabine—colon cancer	0.000136	0.00122	CcSEcCtD
Indinavir—Rash—Fluorouracil—colon cancer	0.000136	0.00122	CcSEcCtD
Indinavir—Dermatitis—Fluorouracil—colon cancer	0.000136	0.00122	CcSEcCtD
Indinavir—Paraesthesia—Capecitabine—colon cancer	0.000135	0.00122	CcSEcCtD
Indinavir—Headache—Fluorouracil—colon cancer	0.000135	0.00121	CcSEcCtD
Indinavir—Dysgeusia—Methotrexate—colon cancer	0.000134	0.00121	CcSEcCtD
Indinavir—Dyspnoea—Capecitabine—colon cancer	0.000134	0.00121	CcSEcCtD
Indinavir—Nausea—Irinotecan—colon cancer	0.000133	0.0012	CcSEcCtD
Indinavir—Back pain—Methotrexate—colon cancer	0.000133	0.00119	CcSEcCtD
Indinavir—Dyspepsia—Capecitabine—colon cancer	0.000132	0.00119	CcSEcCtD
Indinavir—ABCB1—bone marrow—colon cancer	0.000131	0.00811	CbGeAlD
Indinavir—Decreased appetite—Capecitabine—colon cancer	0.000131	0.00118	CcSEcCtD
Indinavir—Gastrointestinal disorder—Capecitabine—colon cancer	0.00013	0.00117	CcSEcCtD
Indinavir—Fatigue—Capecitabine—colon cancer	0.00013	0.00117	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—colon cancer	0.000129	0.00116	CcSEcCtD
Indinavir—Pain—Capecitabine—colon cancer	0.000129	0.00116	CcSEcCtD
Indinavir—Constipation—Capecitabine—colon cancer	0.000129	0.00116	CcSEcCtD
Indinavir—Nausea—Fluorouracil—colon cancer	0.000128	0.00115	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—colon cancer	0.000127	0.00115	CcSEcCtD
Indinavir—Anaemia—Methotrexate—colon cancer	0.000127	0.00114	CcSEcCtD
Indinavir—ABCB1—vagina—colon cancer	0.000126	0.00777	CbGeAlD
Indinavir—Feeling abnormal—Capecitabine—colon cancer	0.000124	0.00112	CcSEcCtD
Indinavir—Malaise—Methotrexate—colon cancer	0.000124	0.00111	CcSEcCtD
Indinavir—Vertigo—Methotrexate—colon cancer	0.000123	0.00111	CcSEcCtD
Indinavir—Gastrointestinal pain—Capecitabine—colon cancer	0.000123	0.00111	CcSEcCtD
Indinavir—Cough—Methotrexate—colon cancer	0.00012	0.00108	CcSEcCtD
Indinavir—Urticaria—Capecitabine—colon cancer	0.000119	0.00107	CcSEcCtD
Indinavir—Body temperature increased—Capecitabine—colon cancer	0.000119	0.00107	CcSEcCtD
Indinavir—Abdominal pain—Capecitabine—colon cancer	0.000119	0.00107	CcSEcCtD
Indinavir—Myalgia—Methotrexate—colon cancer	0.000117	0.00105	CcSEcCtD
Indinavir—Chest pain—Methotrexate—colon cancer	0.000117	0.00105	CcSEcCtD
Indinavir—Arthralgia—Methotrexate—colon cancer	0.000117	0.00105	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000116	0.00104	CcSEcCtD
Indinavir—Discomfort—Methotrexate—colon cancer	0.000115	0.00104	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—colon cancer	0.000112	0.00101	CcSEcCtD
Indinavir—Hypersensitivity—Capecitabine—colon cancer	0.000111	0.000997	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—colon cancer	0.00011	0.000988	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—colon cancer	0.00011	0.000986	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—colon cancer	0.000109	0.000978	CcSEcCtD
Indinavir—Hyperhidrosis—Methotrexate—colon cancer	0.000108	0.000974	CcSEcCtD
Indinavir—Asthenia—Capecitabine—colon cancer	0.000108	0.000971	CcSEcCtD
Indinavir—Anorexia—Methotrexate—colon cancer	0.000107	0.00096	CcSEcCtD
Indinavir—Pruritus—Capecitabine—colon cancer	0.000106	0.000957	CcSEcCtD
Indinavir—ABCB1—liver—colon cancer	0.000106	0.00656	CbGeAlD
Indinavir—Diarrhoea—Capecitabine—colon cancer	0.000103	0.000926	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000102	0.000918	CcSEcCtD
Indinavir—Insomnia—Methotrexate—colon cancer	0.000101	0.000911	CcSEcCtD
Indinavir—Paraesthesia—Methotrexate—colon cancer	0.000101	0.000904	CcSEcCtD
Indinavir—Dyspnoea—Methotrexate—colon cancer	9.98e-05	0.000898	CcSEcCtD
Indinavir—Somnolence—Methotrexate—colon cancer	9.95e-05	0.000895	CcSEcCtD
Indinavir—Dizziness—Capecitabine—colon cancer	9.94e-05	0.000895	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—colon cancer	9.85e-05	0.000887	CcSEcCtD
Indinavir—Decreased appetite—Methotrexate—colon cancer	9.73e-05	0.000876	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—colon cancer	9.66e-05	0.00087	CcSEcCtD
Indinavir—Fatigue—Methotrexate—colon cancer	9.65e-05	0.000868	CcSEcCtD
Indinavir—Pain—Methotrexate—colon cancer	9.57e-05	0.000861	CcSEcCtD
Indinavir—Vomiting—Capecitabine—colon cancer	9.56e-05	0.00086	CcSEcCtD
Indinavir—Rash—Capecitabine—colon cancer	9.48e-05	0.000853	CcSEcCtD
Indinavir—Dermatitis—Capecitabine—colon cancer	9.47e-05	0.000852	CcSEcCtD
Indinavir—Headache—Capecitabine—colon cancer	9.42e-05	0.000848	CcSEcCtD
Indinavir—Feeling abnormal—Methotrexate—colon cancer	9.22e-05	0.00083	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—colon cancer	9.15e-05	0.000824	CcSEcCtD
Indinavir—Nausea—Capecitabine—colon cancer	8.93e-05	0.000804	CcSEcCtD
Indinavir—Urticaria—Methotrexate—colon cancer	8.89e-05	0.0008	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—colon cancer	8.85e-05	0.000796	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—colon cancer	8.85e-05	0.000796	CcSEcCtD
Indinavir—Hypersensitivity—Methotrexate—colon cancer	8.25e-05	0.000742	CcSEcCtD
Indinavir—ABCB1—lymph node—colon cancer	8.14e-05	0.00503	CbGeAlD
Indinavir—Asthenia—Methotrexate—colon cancer	8.03e-05	0.000723	CcSEcCtD
Indinavir—Pruritus—Methotrexate—colon cancer	7.92e-05	0.000713	CcSEcCtD
Indinavir—Diarrhoea—Methotrexate—colon cancer	7.66e-05	0.000689	CcSEcCtD
Indinavir—Dizziness—Methotrexate—colon cancer	7.4e-05	0.000666	CcSEcCtD
Indinavir—Vomiting—Methotrexate—colon cancer	7.12e-05	0.00064	CcSEcCtD
Indinavir—Rash—Methotrexate—colon cancer	7.06e-05	0.000635	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—colon cancer	7.05e-05	0.000635	CcSEcCtD
Indinavir—Headache—Methotrexate—colon cancer	7.01e-05	0.000631	CcSEcCtD
Indinavir—Nausea—Methotrexate—colon cancer	6.65e-05	0.000598	CcSEcCtD
